MedQuest, Inc. Announces Redemption of All Outstanding 11-7/8% Senior Subordinated...

MedQuest, Inc. Announces Redemption of All Outstanding 11-7/8% Senior
Subordinated Notes Due 2012

ALPHARETTA, Ga., Jan. 15 /PRNewswire/ -- MedQuest, Inc. ("MedQuest")
announced today that it has called for redemption all of its outstanding
11-7/8% Senior Subordinated Notes due 2012 (CUSIP No. 58505DAD1) (the
"Notes"). Interest on the Notes will cease to accrue on the redemption date,
which is February 15, 2008. The cash redemption price for the Notes is
105.938% of the outstanding principal amount thereof. MedQuest will also pay
accrued and unpaid interest of $59.38 for each $1,000 principal amount of the
Notes redeemed, which represents accrued and unpaid interest up to, but not
including, the redemption date. As of January 15, 2008, $177,168,000
aggregate principal amount of the Notes were outstanding.
The formal redemption notice required by the indenture pursuant to which
the Notes were issued has been sent to the trustee. The redemption of the
Notes and the payment of the redemption price will be in accordance with the
terms specified in the redemption notice and the redemption procedures of the
trustee
Forward Looking Statements
This press release contains or may contain forward-looking statements
within the meaning of the Private Securities Litigation Reform Act of 1995.
Such statements include, without limitation, statements regarding MQ
Associates' future growth and profitability, growth strategy and trends in the
industry in which it operates. These forward-looking statements are based on
MQ Associates' current expectations and are subject to a number of risks,
uncertainties and assumptions. MQ Associates can give no assurance that such
forward-looking statements will prove to be correct. Among the important
factors that could cause actual results to differ significantly from those
expressed or implied by such forward-looking statements are the recently
closed merger with Novant, general economic and business conditions, the
effect of healthcare industry trends on third-party reimbursement rates and
demand for its services, limitations and delays in reimbursement by
third-party payors, changes in governmental regulations that affect its
ability to do business, actions of its competitors, introduction of new
technologies, risks associated with its acquisition strategy and integration
costs, and the additional factors and risks contained in MQ Associates' Annual
Report on Form 10-K for the year ended December 31, 2006, as well as its other
periodic reports filed with the SEC. MQ Associates undertakes no obligation to
publicly update or review any forward-looking statement, whether as a result
of new information, future developments or otherwise, except as otherwise
required by law.
MedQuest is a leading operator of independent, fixed-site, outpatient
diagnostic imaging centers in the United States. MedQuest centers provide
high quality diagnostic imaging services using a variety of technologies
including magnetic resonance imaging (MRI), computed tomography (CT), nuclear
medicine, general radiology, bone densitometry, ultrasound and mammography.
MedQuest operates a network of 92 centers in 13 states located primarily
throughout the southeastern and southwestern United States.
SOURCE MedQuest

Maggie Sayre, Public Relations Representative for MQ Associates, Inc.,
+1-202-460-3647, maggie@sayreconsulting.com